Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California


Recent News and Articles on the Keywords: aids + drug + boehringer  Related to the article below (Last Update: 12/1/2008)

 News results: Standard Version | Text Version | Image Version Results 1 - 8 of about 9 for aids drug boehringer. (0.24 seconds) 
Recent
Archives
  • All dates
  • 2004-06
  • 2003
  • 2002
  • 2001
  • 2000

 Sorted by relevance   Sort by date   Sort by date with duplicates included 
Mbeki Aids policy 'led to 330000 deaths'
guardian.co.uk, UK - Nov 26, 2008
In July 2000 the pharmaceutical company Boehringer Ingelheim offered to donate its drug nevirapine, which could prevent the transmission of HIV from mother ...
South Africa: 330000 Lose Lives Due to ARV Delay - Harvard Study AllAfrica.com
all 297 news articles »
High Growth Reported for the World Pharmaceuticals Market Brief
MarketWatch - Nov 18, 2008
Clav., and Tramadol 9 Leading Generic Drug Companies 10 Table 12: Leading Companies in the Global Pharmaceutical Market by Healthcare Research and ...
Germany Pharmaceuticals and Healthcare Report Q3 2008 - Companies ...
Live-PR.com (Pressemitteilung), Austria - Nov 24, 2008
Boehringer Ingelheim received positive news from the European Commission after their new drug Pradaxa (dabigatran etexilate) gained approval for marketing ...
The Global HIV AIDS Market Outlook to 2012 - New Research Report ...
Live-PR.com (Pressemitteilung), Austria - Nov 17, 2008
... Gilead, BMS, Abbott, Roche, Boehringer Ingelheim, Pfizer, Merck, Barr and Kohl Medical. ? Discover which HIV drug classes have the greatest potential to ...
Thousands of lives lost in treatment delays
Plus News, South Africa - Nov 7, 2008
The authors pointed out that the South African government declined the offer of free nevirapine from pharmaceutical manufacturer Boehringer Ingelheim in ...
Brazil Pharmaceuticals and Healthcare Report Q3 2008 - http://www ...
Live-PR.com (Pressemitteilung), Austria - Nov 26, 2008
The government declared Gilead?s AIDS drug Tenofovir (disoproxil fumarate) ?in the public interest? in April, indicating it could reject a patent request ...
Foreign Investment in Pharmaceuticals Hampered by Regulations
Tempo Interaktif, Indonesia - Nov 6, 2008
However incoming investors are carrying out research in medicines to cure cancer, AIDS, and the avian flu. "They are not our competitors," he told Tempo ...
Rodman & Renshaw Annual Global Investment Conference Presenter ...
TMC Net, CT - Nov 7, 2008
Vitae also has an 11-beta HSD1 diabetes / metabolic syndrome program, partnered in 4Q 2007 with Boehringer-Ingelheim, and an early but rapidly progressing ...RODM
Source: Google News


 

Recent News and Articles on the Keywords: 0.18 + boehringer + web  Related to the article below (Last Update: 8/7/2008)

Tele2Tango launches international discount plan
Telecom Paper (subscription), Netherlands - 13 minutes ago
Subscribers receive a discounted rate of EUR 0.09 per minute to fixed lines and EUR 0.18 per to mobiles in the designated country. ...

RTT News
AQUA AMERICA REPORTS SECOND QUARTER EARNINGS
MarketWatch -
... Basic net income per common share $ 0.17 $ 0.18 $ 0.28 $ 0.31 ======== ======== ======== ======== Diluted net income per common share $ 0.17 $ 0.18 ...
China Digital TV Announces Unaudited Second Quarter 2008 Results Earthtimes (press release)
Lydall Announces Financial Results for the Second Quarter and Six ... CNNMoney.com
China Security & Surveillance Technology Reports Second Quarter ... eMediaWorld.com Newswire Press Release Distribution Service (press release)
MarketWatch - Earthtimes (press release)
all 616 news articles »  CSR - LDL - WFMI
Allied Cap Corp (ALD) holdings reduced by Emerson Investment ...
Mffais.com, CA -
The stock is currently owned by 223 funds/institutions with a total activity score of 0.18. With 50.00 % of owning funds reported recently buying shares, ...
Allied Capital Announces Second Quarter 2008 Financial Results Trading Markets (press release)
all 6 news articles »  ALD
*SHENZHEN B-SHARE INDEX OPENS DOWN 0.18 PTS AT 459.49
華富財經, Hong Kong - Jul 30, 2008
In relation to the stock quote service (the "Quote Service") information, the stock price, trade volume and turnover are provided by The Stock Exchange of ...
Hong Kong shares end morning off highs; earnings disappointments ...
Forbes, NY -
Hunan Nonferrous Metals tumbled 0.18 hkd or 10.23 pct to 1.58 after the company said its net profit for the six months ended June may decrease significantly ...
Quaterra extends area of primary copper mineralization in the ...
CNW Telbec (Communiqu?s de presse), Canada -
... 275.0 10.0 0.54 320.0 340.0 20.0 0.23 365.0 395.0 30.0 0.17 QM-040 270/-60 415 0.0 140.0 140.0 0.19 190.0 260.0 70.0 0.23(*) 315.0 415.0 100.0 0.18(*) ...CVE:QTA - TSE:X - QMM
First American Corp. Leads Thursday's AMBG as Global Insurance ...
Trading Markets (press release), CA - Aug 1, 2008
Leading the AMBUML were Horace Mann Educators (+1.69%) and Unitrin (+0.18%). Trailing the AMBUML were Assurant (-6.82%) and American National Insurance ...FAF - FMR - LON:NVA
BOVESPA: Index falls 0.18%, to 59890 points
Gazeta Mercantil, Brazil - Jul 31, 2008
S?O PAULO, 7/31/08 - The S?o Paulo Stock Exchange (Bovespa) reduced the losses seen in the beginning of the session and, a short while ago, fell 0.18%, ...
Geokinetics Announces Second Quarter 2008 Results
MarketWatch -
... Income applicable to common stockholders $(1846) $(15450) Loss per common share - basic $(0.18) $(1.95) Loss per common share - diluted $(0.18) $(1.95) ...
Hill International Announces Record Second Quarter 2008 Financial ... MarketWatch
all 285 news articles »  HIL
Source: Google News

Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat -
S Uhlig, L Wollin, A Wendel - Journal of Applied Physiology, 1994 - Am Physiological Soc
... WEB-2086 {3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f]- [1,2,4 ... a][1,4]-diazepin-
2-yl]-l-(4-morpholinyl)- 1-propanon} was from Dr. Heuer (Boehringer Ingelheim ...

WEB 2086, a platelet-activating factor antagonist, inhibits prophenoloxidase-activating system and … -
EMM Machado, P Azambuja, ES Garcia - Journal of Insect Physiology, 2006 - Elsevier
... antagonist WEB 2086, donated by Boehringer Ingelheim, Germany ... 2.42?0.13 units),
(iii) treatment with WEB 2086 and PAF in conjuction (2.40?0.18 units) and ...

[PDF] XMM-Newton high-resolution spectroscopy reveals the chemical evolution of M 87 -
N Werner, H Boehringer, JS Kaastra, J de Plaa, A … - Arxiv preprint astro-ph/0608177, 2006 - arxiv.org
... area corrections found by one of us (Jacco Vink; more information can be found on
the web- site of the ... Y 1 0.82 ? 0.04 0.23 ? 0.03 0.16 ? 0.02 0.18 ? 0.02 ...
-

WEB BASED LEARNING MODULES FOR INTERVENTIONAL PULMONARY PROCEDURES: LASER THERAPY AND STENT …
P NGUYEN, P ROBINSON, H COLT, M CHIA, M HOLMES, H … - Respirology, 2007 - pt.wkhealth.com
... A skill based education program was developed combining on-line interactive tutorials
and competency assessments that are accessible via the web at anytime. ...

Effects of platelet-activating factor on ?-and H 2-receptor-mediated increase of myocardial … -
SB Felix, G Baumann, M Niemczyk, Z Ahmad, T … - Research in Experimental Medicine, 1991 - Springer
... 4 )-diazepine- 2- y? )- I-( 4-m?rph??iny?)-1- propanone) was kindly provided
by Boehringer (Ingelheim, FRG). ... 3 PAF WEB 2086 (0.18 nmol) (3.65 ...

Changes in Content of Purine Nucleoside in Canine Myocardium during Coronary Occlusion -
RA OLSSON - Circulation Research, 1970 - Am Heart Assoc
... and services, is located on the World Wide Web at: The ... 2 Miltex Corp., New York,
NY 8 Boehringer Mannheim Corp ... Taai 0.09 =?? 0.18 ? 0.26 ? 0.44 ? 0.86 ? ...

… LEARNING OF CRITICAL CARE PHARMACOTHERAPY: EVALUATION OF A FORMALIZED WEB-BASED EDUCATIONAL MODEL
N Weimert, BR Zeno, J Mazur, A Boylan - Chest, 2005 - Am Coll Chest Phys
Page 1. INTERLEUKIN 2 INCREASES ALVEOLAR FLUID CLEAR- ANCE IN ISOLATED
RAT LUNGS Makoto Sugita MD* Zheng Wang MD Sumiko Maeda MD ...

Critical Duration of Intracellular Ca2+ Response Required for Continuous Translocation and … -
T Hirabayashi, K Kume, K Hirose, T Yokomizo, M … - Journal of Biological Chemistry, 1999 - ASBMB
... leukotriene B 4 were generous gifts from Boehringer Ingelheim (Germany ... analysis of
the binding of [ 3 H]WEB 2086 or ... 5 min in the buffer containing 0.18, 1.8, or ...

-
AS Prokopowicz III, MP Brown, JM Wildeson, S Jakes … - US Patent 7,125,996, 2006 - Google Patents
... (73) Assignee: Boehringer Ingelheim Pharmaceuticals ... 0.18 ... The seventh edition is available
on CD-ROM and an updated seventh edition is available on the Web at www ...

Platelet-activating factor does not mediate circulatory failure induced by 35-GHz microwave heating -
KL RYAN, JR JAUCHEM, MR TEHRANY, HL BOYLE - Methods Find. Exp. Clin. Pharmacol, 2002 - journals.prous.com
... Drugs WEB 2086 was generously provided by Boehringer- Ingelheim (Ridgefield ... WEB 2086
was solu- bilized in 0.9% NaCl immediately ... were in a volume of 0.18-0.19 ml ...

Source: Google Scholar
 
 

Boehringer says AIDS drug works in children

FRANKFURT - German drugmaker Boehringer Ingelheim's AIDS drug Aptivus helped reduce amounts of the virus in children, according to results of a study, the company said on Monday.

Boehringer said results from a 48-week analysis of the 115-child trial showed that patients achieved a decrease in virologic load, which measures the amount of virus in the blood.

They experienced an increase in so-called CD4+ cells that protect the body against infection.

All but three of the children had undergone other treatments in the past and were infected with strains of the AIDS-causing HIV virus that showed high levels of resistance to other drugs.

 

 

Aptivus, or tipranavir, competes with rivals from GlaxoSmithKline, Roche, Pfizer and Merck & Co.

Unlisted Boehringer said in a statement it planned to apply for European approvals next year for the use of tipranavir in HIV-infected children who had received prior treatment with other drugs.

The results of the study were presented at the 16th International AIDS Conference in Toronto, Canada.

Boehringer was recently ousted as Germany's top drugmaker by sales by Bayer, which has acquired rival Schering for about 17 billion euros ($22 billion).

 
 
 
Google
Web www.iconocast.com
 

 

Continue News With:News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords:

Contact Iconocast

Home Page